VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
Vienna

Executive Profile*

Jeffrey M. Leiden M.D., Ph.D.

Chairman, Chief Executive Officer and President,Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 129 board members in 6 different organizations across 10 different industries.

See Board Relationships
60$17,419,758
As of Fiscal Year 2016

Background*

Dr. Jeffrey M. Leiden, also known as Jeff, M.D., Ph.D. has been the Chairman of Vertex Pharmaceuticals Incorporated since May 2012 and has been its Chief Executive Officer and has also been President since February 1, 2012. Dr. Leiden serves as a Senior Advisor at Clarus Ventures, LLC. He has more than 20 years of scientific, commercial and financial experience in the pharmaceutical and biotechnology industries as well as clinical and scientific experience in academia ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Member of Executive Committee of Board of Trustees
Trustee
Trustee
2009-Present
Chairman, Chief Executive Officer and President
2014-Present
Director
2015-Present
Director

Education*

MA
Harvard University
PhD
The University of Chicago
BA
The University of Chicago
MD
The University of Chicago

Other Affiliations*

Annual Compensation*

Salary$1,300,000
Total Annual Compensation$1,300,000

Stock Options*

Restricted Stock Awards$9,800,076
All Other Compensation$12,885
Exercisable Options1,010,528
Exercisable Options Value$19,474,720
Unexercisable Options424,383
Unexercisable Options Value$315,959
Total Value of Options$19,790,679
Total Number of Options1,434,911

Total Compensation*

Total Annual Cash Compensation$3,559,285
Total Short Term Compensation$1,300,000
Other Long Term Compensation$9,812,961
Total Calculated Compensation$17,419,758
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Martine A. Rothblatt Ph.D., J.D., M.B.A.Founder, Chairman of the Board and Chief Executive Officer
United Therapeutics Corporation
$1.2M
Stephen Edward Foots Group Chief Executive and Executive Director
Croda International plc
1.4M GBP
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
SFr.2.8M
Heinz-Jürgen Bertram Ph.D.Chairman of Executive Board, Chief Executive Officer, Labour Director and President of Flavor & Nutrition Worldwide
Symrise AG
€1.2M
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director & CEO
Dr. Reddy's Laboratories Limited
18.5M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.